Shanghai's breast cancer treatment ranks among the world's leading levels, with mature breast-conserving surgery and targeted therapy technologies, providing international patients with comprehensive solutions that combine efficacy and quality of life. Compared with Europe and the US, treatment costs in Shanghai are more advantageous, with experienced multidisciplinary expert teams.
Technical advantages of breast-conserving surgery
For eligible early-stage breast cancer patients, breast-conserving surgery completely removes the tumor while preserving breast appearance, and postoperative radiotherapy achieves treatment outcomes comparable to mastectomy. Multiple hospitals in Shanghai have mature technologies in breast-conserving surgery, sentinel lymph node biopsy and postoperative reconstructive plastic surgery.
Targeted and immunotherapy
Based on genetic testing results, patients with different subtypes such as HER2-positive and hormone receptor-positive can receive corresponding targeted therapy, and some can also combine immunotherapy, significantly improving response rates and survival. Multidisciplinary teams (MDT) develop individualized plans for each patient.
Cost advantage
Comprehensive breast cancer treatment costs in Shanghai are usually about one-third of those in Europe and the US. Drugs such as targeted therapies included in medical insurance further reduce patients' out-of-pocket ratios.
Treatment process for international patients
Patients are advised to submit pathology and imaging data for remote consultation to clarify staging and treatment direction before traveling to Shanghai. MedBridge can connect patients with oncology experts in Shanghai, providing booking, interpretation accompaniment and follow-up services.